Manchester 6 - 8 October 2023

Scientific Session - Research & Innovation

Competition - Oral & Poster presentation on Saturday the 7th of October 2023

British Association of Physicians of India (BAPIO) is pleased to announce the Research & Innovation Competition (R&I Competition) at its Annual Conference 'NHS Inequalities: Policies, Solutions and Implementation'. This year’s conference provides exciting opportunity to present innovative and progressive solutions to the current healthcare challenges.

Key outputs from the R&I Competition include:

a)       To identify sustainable measures to address health inequalities 

b)      To identify key challenges faced by healthcare workers, explore solutions and its implementation

c)       Learn about successful and innovative models of healthcare delivery

d)      Novel bench and translation research that will transform patient care

e)      Quality Improvement project or Audit cycle demonstrating sustainable change in practice

The research and innovation competition invites enthusiastic and inspired medical students, research students, doctors in training, LED, SAS doctors and healthcare professionals to present their work to their peers. We encourage structured abstract submissions across a range of physical health/ mental health/ workforce related topics using one of the following themes:

Medical Laboratory research

Clinical/translational research

Innovation in patient pathway

Patient experience and safety

Audit cycle and/or Quality improvement project

Big data research

Eligibility:

Medical students, health science EPQ students, research students (MSc, MD or PhD), doctors in training, LED, SAS doctors and healthcare professionals from the UK and abroad, irrespective of nationality or ethnicity can participate as presenting authors in this competition. 

Competition Categories:

For competition two broad categories based on roles at the time of the work submitted:

1) Medical students & Health sciences EPQ students

2) Academic & Non-academic doctors and healthcare professionals (including doctors in training and non-training posts, SAS, trust grade, MTI doctors, Locally Employed Doctors or fellows). Consultants are welcome to submit along with their teams, though we encourage junior doctors to present. Non-medical healthcare professionals are welcome to submit under this category. 

This will be three stage process and two competitions (oral and poster) -

1. Stage 1 - The abstracts will be sorted into two broad categories as above.

2. Stage 2 - All abstracts will be scored by multiple independent assessors.

3. Stage 3 - Top 10 abstracts in either category would be invited for oral podium presentation (4 minutes, max 5 ppt slides, 2 mins for questions/ discussion) on day-2 of the conference (Saturday, 7th October 2023 in Manchester) 

Podium Awards:

Medical students and Health sciences EPQ students’ category

a) First prize (£200)

b) Second prize (£150)

c) Third Prize (£50)

Academic & Non-academic doctors and healthcare professionals category

a) First prize (£500)

b) Second prize (£250)

c) Third Prize (£100)

All 4 winners would be awarded a medal along with prize amount. All oral presenters would be awarded certificates.

Poster Presentation & Awards:

All other abstracts (excluding top 20 above) will be invited for electronic poster presentation competition and will have prizes in two broad categories:

Medical students and Health sciences EPQ students’ category

a) First prize (£175)

b) Second prize (£75)

Academic & Non-academic doctors category

a) First prize (£175)

b) Second prize (£75)

All poster presenters would be awarded certificates. 

Important Dates

Abstract Submission Opens: 7th August 2023

Abstract Submission Closes: 28th September 2023

Notification of selected abstracts: by 2rd of October 2023

(via email)

Selected presentation and posters uploaded: by 5th of October 2023

How to register/ submit abstract :

There is no fee for submission of abstract and discounted rate for students and trainees for registration for the conference. The presenting/ first author of the selected abstract for presentation must register for the conference. 

To submit abstract: https://forms.gle/dasbZo6VC7YhMZM18   

Please visit for registration - Link will be available soon

Please email submission.bapioac2023@gmail.com for any other queries.

Guidelines for Abstract Submission:

▪ Submissions must be via the BAPIO Annual Conference 2023 Abstract submission online portal – google form below and link on BAPIO website.

▪ The data/abstract should not have been published in any scientific journal prior to submission.

• Please limit the abstract to 300 words and include the following sub-headings: Background and aims, Methods, Results, Conclusion. Over 300 words will disqualify your submission and no edit allowed after closing date. The word count includes the title, the sub-headings and a maximum of 5 keywords.

▪ Abstracts will be independently scored by panel of experts and highest scoring abstracts will be invited for oral presentations.

▪ All abstracts that meet quality and eligibility criteria would be invited for a poster presentation.  

  Posters will be displayed electronically / physically (tbc).

▪ Please ensure all co-authors have agreed to submission for the conference and publication of abstract in conference proceedings - The Physician (BAPIO Journal).

▪ Please try to avoid acronyms and abbreviations as much as possible. Where essential, use only standard abbreviations. When first used, always insert the full term in the text and the acronym in parenthesis.

▪ Presenting authors must submit the final presentation ppt at least 3 days before the date of the conference by email to - submission.bapioac2023@gmail.com

Guidelines for Poster Presentation

Posters would be e-posters. Please submit in form of high quality pdf and ppt (format tbc) to enable presentation on large screen monitors. The poster presenters would be given specific time slot for presentation to the judges during poster walk-in session on 7th October 2023

Sample Abstract

Authors: Marcello Sala1, M. Miceli1, P. Rombolà, F. Scolamacchia2, A. Ubaldi and A. Battisti (list any institutional affiliations here)

Institute /Affiliations:

1. Dept. of Genetics, Institute of Human Studies, Any Road, Anywhere, A12 9BC

2. Dept. of Surgery, Anywhere NHS Foundation Trust, Any Road, Anywhere, A12 9BC

Address: Anywhere NHS Foundation Trust, Any Road, Anywhere, A12 9BC

e-mail: doctorwho@xyzabc.com

Title: High‐Level Beta‐Hexachlorocyclohexane Contamination in Dairy Farms—Sacco River Valley, Latium, Italy, 2005

Abstract:

Background: In March 2005, the Italian National Monitoring System on Chemical Residuals in Food of Animal Origin detected levels of the pesticide beta‐hexachlorocyclohexane (ß‐HCH) in bulk‐milk from a dairy farm in the Sacco River valley that were 30 times higher than the legal limit of 3ppb. A study was therefore undertaken to evaluate the extent and risk factors for contamination.

Methods: All dairy cattle farms in the valley were enrolled in a retrospective cohort study and their bulk milk analysed for ß‐HCH. A questionnaire was administered to farmers to evaluate possible exposure factors. Low‐level contamination was defined as ß‐HCH levels in bulk‐milk between 0‐1.9ppb and high‐level as >2ppb.

Results: Of 244 farms tested, 34 (13,9%) had high‐level contamination. Feeding animals on fodder cultivated in soils watered with and/or flooded by river water was observed in 33/34 (97.0%) of high‐level farms and in 23/210 (10.9%) of those with low contamination (relative risk =110.8; 95%confidence interval 15.5‐792); the risk remained essentially unaltered after controlling for several potentially confounding variables.

Conclusions: Cattle fodder cultivated near a contaminated river was the main risk factor for ß‐HCH contaminated milk. On the basis of the epidemiologic evidence and environmental testing, watering local fields with river water and production of fodder in farms with contaminated soil was banned, and all animals from positive farms were culled.

Keywords: beta‐hexachlorocyclohexane, organochlorines, milk, cattle, cohort study